Search Results - "Lizzul, Paul F"

ATX-101 for reduction of submental fat: A phase III randomized controlled trial by Humphrey, Shannon, MD, Sykes, Jonathan, MD, Kantor, Jonathan, MD, MSCE, MA, Bertucci, Vince, MD, Walker, Patricia, MD, PhD, Lee, Daniel R., MS, Lizzul, Paul F., MD, PhD, MPH, MBA, Gross, Todd M., PhD, Beddingfield, Frederick C., MD, PhD

“…Background ATX-101, an injectable form of deoxycholic acid, causes adipocytolysis when injected subcutaneously into fat. Objective We sought to evaluate the…”
Get full text

Association between pediatric psoriasis and the metabolic syndrome by Au, Shiu-chung, MD, Goldminz, Ari M., BA, Loo, Daniel S., MD, Dumont, Nicole, Levine, Danielle, MD, Volf, Eva, MD, Michelon, Melissa, MD, Wang, Andrew, MD, Kim, Noori, MD, Yaniv, Shimrat, BA, Lizzul, Paul F., MD, PhD, MBA, MPH, Kerensky, Todd, MD, Lopez-Benitez, Jorge M., MD, Natter, Marc, MD, Miller, Laurie, MD, Pelajo, Christina F., MD, MSc, Davis, Trevor, MD, Gottlieb, Alice B., MD, PhD

Get full text

Physician performance measurement: Tiered networks and dermatology (An opportunity and a challenge) by Freedman, John D., MD, MBA, Gottlieb, Alice Bendix, MD, PhD, Lizzul, Paul F., MD, PhD, MPH, MBA

Get full text

REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction by Jones, Derek H, Carruthers, Jean, Joseph, John H, Callender, Valerie D, Walker, Patricia, Lee, Daniel R, Subramanian, Meenakshi, Lizzul, Paul F, Gross, Todd M, Beddingfield, 3rd, Frederick C

“…ATX-101, an injectable form of deoxycholic acid, is approved in the United States and Canada for submental fat (SMF) reduction. To report results of REFINE-1,…”
Get full text

A phase I safety and pharmacokinetic study of ATX-101: injectable, synthetic deoxycholic acid for submental contouring by Walker, Patricia, Fellmann, Jere, Lizzul, Paul F

“…ATX-101 (deoxycholic acid [DCA] injection) is a proprietary formulation of pure synthetic DCA. When injected into subcutaneous fat, ATX-101 results in focal…”
Get more information

Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental Fat by Dayan, Steven H, Humphrey, Shannon, Jones, Derek H, Lizzul, Paul F, Gross, Todd M, Stauffer, Karen, Beddingfield, 3rd, Frederick C

“…In 2015, ATX-101 (deoxycholic acid injection; Kybella in the United States and Belkyra in Canada; Kythera Biopharmaceuticals, Inc., Westlake Village, CA [an…”
Get full text

Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat by Dover, Jeffrey S, Kenkel, Jeffrey M, Carruthers, Alastair, Lizzul, Paul F, Gross, Todd M, Subramanian, Meenakshi, Beddingfield, 3rd, Frederick C

“…ATX-101 (deoxycholic acid injection; Kythera Biopharmaceuticals, Inc., Westlake Village, CA [an affiliate of Allergan plc, Dublin, Ireland]) was recently…”
Get full text

Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials by Dayan, Steven H, Schlessinger, Joel, Beer, Kenneth, Donofrio, Lisa M, Jones, Derek H, Humphrey, Shannon, Carruthers, Jean, Lizzul, Paul F, Gross, Todd M, Beddingfield, Frederick C, Somogyi, Christine

“…Abstract Background ATX-101 (deoxycholic acid injection) is the only injectable drug approved for submental fat (SMF) reduction. In the phase 3 REFINE trials,…”
Get full text

Differential Expression of Phosphorylated NF-κB/RelA in Normal and Psoriatic Epidermis and Downregulation of NF-κB in Response to Treatment with Etanercept by Lizzul, Paul F., Aphale, Abhishek, Malaviya, Rama, Sun, Yvonne, Masud, Salman, Dombrovskiy, Viktor, Gottlieb, Alice B.

“…Etanercept, a recombinant human tumor necrosis factor (TNF) receptor fusion protein, is FDA approved for psoriasis and psoriatic arthritis. TNFα increases the…”
Get full text

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis by Au, Shiu-Chung, Goldminz, Ari M., Kim, Noori, Dumont, Nicole, Michelon, Melissa, Volf, Eva, Hession, Meghan, Lizzul, Paul F., Andrews, Israel D., Kerensky, Todd, Wang, Andrew, Yaniv, Shimrat, Gottlieb, Alice B.

“…Abstract Background: Palmoplantar psoriasis is a variant of psoriasis resistant to many forms of treatment. Methods: Twenty subjects with moderate-to-severe…”
Get full text

Management of psoriatic arthritis from the view of the dermatologist by Gottlieb, Alice B, Chang, Caroline A, Lizzul, Paul F

“…Untreated psoriatic arthritis can have severe long-term consequences, and patients benefit from early intervention. The disease typically presents as psoriasis…”
Get full text

Prevalence of the Metabolic Syndrome in Children with Psoriatic Disease by Goldminz, Ari M., Buzney, Catherine D., Kim, Noori, Au, Shiu-Chung, Levine, Danielle E., Wang, Andrew C., Volf, Eva M., Yaniv, Shimrat S., Kerensky, Todd A., Bhandarkar, Manasa, Dumont, Nicole M., Lizzul, Paul F., Loo, Daniel S., Kulig, John W., Brown, Mary E., Lopez-Benitez, Jorge M., Miller, Laurie C., Gottlieb, Alice B.

“…Adults with psoriasis have a greater risk of developing metabolic syndrome (MetS) and cardiovascular disease (CVD), but few studies have investigated the…”
Get full text

The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation by Lizzul, Paul F, Narurkar, Vic A

“…Radiesse (Bioform Medical, San Mateo, CA) is a synthetic calcium hydroxylapatite microsphere filler suspended in an aqueous carrier gel. Radiesse currently has…”
Get more information

Cutaneous clues to renal cell carcinoma: hereditary leiomyomatosis and renal cell carcinoma by Michelon, Melissa A, Layton, Christle J, Jessup, Chad J, Lizzul, Paul F

“…We present a case of a 33-year-old female who was incidentally found to have cutaneous leiomyomata during a routine skin examination. Further history revealed…”
Get more information

A Pooled Analysis of the Safety and Efficacy Results of the Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 3 REFINE-1 and REFINE-2 Trials of ATX-101, a Submental Contouring Injectable Drug for the Reduction of Submental Fat by Dayan, Steven H., Jones, Derek H., Carruthers, Jean, Humphrey, Shannon, Brandt, Fredric S., Walker, Patricia, Lee, Daniel, Lizzul, Paul F., Gross, Todd, Beddingfield, Frederick C.

Get full text

Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept by Lizzul, Paul F, Aphale, Abhishek, Malaviya, Rama, Sun, Yvonne, Masud, Salman, Dombrovskiy, Viktor, Gottlieb, Alice B

“…Etanercept, a recombinant human tumor necrosis factor (TNF) receptor fusion protein, is FDA approved for psoriasis and psoriatic arthritis. TNFalpha increases…”
Get full text

Identification and characterization of TAPIR, a novelc-Rel target gene that can suppress NF-kappaB-mediated gene activation by Lizzul, Paul F

“…The NF-κB transcription factors are central mediators of many pathologic conditions, ranging from autoimmune and inflammatory disorders to cancer. Using PCR…”
Get full text

Identification and characterization of TAPIR, a novel c -Rel target gene that can suppress NF -kappaB -mediated gene activation by Lizzul, Paul F

“…The NF-κB transcription factors are central mediators of many pathologic conditions, ranging from autoimmune and inflammatory disorders to cancer. Using PCR…”
Get full text

Impact of Accountable Care Organizations on Psoriasis Care by Kim, Noori, Cressey, Brienne, Do, Michael, Wang, Rona, Gottlieb, Alice B., Lizzul, Paul F.

“…The Center for Medicare and Medicaid Services implemented the groundwork for health care providers to use integrated delivery models, such as accountable care…”
Get full text